GB Patent

GB0412181D0 — Biological products

Assigned to Celltech R&D Ltd · Expires 2004-06-30 · 22y expired

What this patent protects

Patent listed against Ozempic.

Drugs covered by this patent

Ozempic (semaglutide) · Novo Nordisk

Patent Metadata

Patent number: GB0412181D0
Jurisdiction: GB
Classification: —
Expires: 2004-06-30
Drug substance claim: No
Drug product claim: No
Assignee: Celltech R&D Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.